지에프씨생명과학

388610KOSDAQ기타 화학제품 제조업

41.3 / 100

Reference Date: 2026-06-10

Financial Score8.0 / 40

News Sentiment21.3 / 25

Momentum2.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, PER raises overvaluation concerns. Plunged 34.2% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

GFCC Life Sciences operates two main business units: the Material Business Unit, which develops innovative cosmetic ingredients using skin microbiome and exosome technologies, and the Clinical Business Unit, which provides human efficacy testing services for cosmetics. The Material Business Unit leverages a library of over 2,000 strains and proprietary patents to produce high-value raw materials, expanding into the growing skin booster market. The Clinical Business Unit benefits from increased demand for efficacy verification due to regulatory changes, driving sustained revenue growth.

Number of Employees

86people

Average Salary

47.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

54.78Industry Average 16.500.0Point

3.3x industry avg (risky)

PBR

1.40Industry Average 1.132.5Point

Higher than industry avg (caution)

ROE

3.20Industry Average 4.552.5Point

Below industry avg

Debt Ratio

33.67Industry Average 8.130.0Point

4.1x industry avg (risky)

Trend 2024~20253.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲5.4% (1-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼77.3% (1-year basis)

ROE Trend

1.0 / 4

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Positive
지에프씨생명과학, 1분기 매출·영업익·순익 '트리플 성장'
지에프씨생명과학의 매출, 영업이익, 순이익이 각각 12.2%, 16.7%, 59.9% 증가하며 트리플 성장을 달성했다.
Positive
지에프씨생명과학 "수출 확대로 1분기 호실적…수익성 개선 가속"
지에프씨생명과학은 글로벌 수출 증가와 자체 브랜드 확장으로 인해 매출과 수익성이 크게 향상되었다.
Positive
지에프씨생명과학 "화장품 유통·신제품 강화…실적 성장 자신"
지에프씨생명과학의 신제품 출시와 유통 채널 확장으로 인해 실적이 크게 향상되어 긍정적인 시장 반응을 보임.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 6,300Won52-week high 32,55052-week low 6,300

1-month return0.0Point

1m -34.24% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-05-22
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-22
Neutral기업설명회(IR)개최2026-05-20
Neutral분기보고서 (2026.03)2026-05-13